Log in

600538 Beihai Gofar Chuanshan Biological Co. Ltd. SSE · China

Beihai Gofar Chuanshan Biological Co. (600538) news

Beihai Gofar Chuanshan Biological Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600538, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Beihai Gofar Chuanshan Biological Co. news

We have not published a story on Beihai Gofar Chuanshan Biological Co. yet. When there is news, it will appear here.

Questions about Beihai Gofar Chuanshan Biological Co.

What is the ticker symbol of Beihai Gofar Chuanshan Biological Co.?

Beihai Gofar Chuanshan Biological Co. Ltd. trades under the ticker 600538 on SSE.

Where is Beihai Gofar Chuanshan Biological Co. listed?

Beihai Gofar Chuanshan Biological Co. Ltd. is listed on SSE.

Which country or territory is Beihai Gofar Chuanshan Biological Co. listed under?

Our directory records Beihai Gofar Chuanshan Biological Co. Ltd. under China.

What does Beihai Gofar Chuanshan Biological Co. do?

Our directory classifies Beihai Gofar Chuanshan Biological Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Beihai Gofar Chuanshan Biological Co.?

The ISIN recorded for Beihai Gofar Chuanshan Biological Co. Ltd. is CNE000001DD2.

Does aibio.space cover Beihai Gofar Chuanshan Biological Co.?

aibio.space lists Beihai Gofar Chuanshan Biological Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Beihai Gofar Chuanshan Biological Co.?

Companies in our directory listed in the same country and business area as Beihai Gofar Chuanshan Biological Co.: Consun Pharmaceutical Group, Clover Biopharmaceuticals, Shandong Lukang Pharmaceutical Co., Hunan Fangsheng Pharmaceutical Co., ImmuneOnco Biopharmaceuticals (Shanghai), Yabao Pharmaceutical Group Co..

Investor discussion: Beihai Gofar Chuanshan Biological Co.

Members talk about Beihai Gofar Chuanshan Biological Co. (600538). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:600538 on TradingView.

Listing details

Beihai Gofar Chuanshan Biological Co. Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 600538, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Beihai Gofar Chuanshan Biological Co. Ltd.
Ticker
600538
Listing
SSE
Country or territory
China
Business scope
Pharmaceuticals: Major
ISIN
CNE000001DD2
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.